Compare DAWN & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAWN | STRA |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2021 | 1996 |
| Metric | DAWN | STRA |
|---|---|---|
| Price | $21.42 | $81.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $26.00 | ★ $92.67 |
| AVG Volume (30 Days) | ★ 6.4M | 307.1K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.88% |
| EPS Growth | N/A | ★ 15.85 |
| EPS | N/A | ★ 5.41 |
| Revenue | $158,182,000.00 | ★ $997,137,000.00 |
| Revenue This Year | $55.03 | $3.93 |
| Revenue Next Year | $28.12 | $4.93 |
| P/E Ratio | ★ N/A | $15.43 |
| Revenue Growth | 20.60 | ★ 57.23 |
| 52 Week Low | $5.64 | $72.17 |
| 52 Week High | $21.46 | $92.98 |
| Indicator | DAWN | STRA |
|---|---|---|
| Relative Strength Index (RSI) | 81.44 | 50.64 |
| Support Level | $10.30 | $78.36 |
| Resistance Level | N/A | $85.70 |
| Average True Range (ATR) | 0.07 | 2.17 |
| MACD | -0.16 | 0.20 |
| Stochastic Oscillator | 79.55 | 56.49 |
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.